Company Overview
Company Name
Galectin Therapeutics
Address
United States
Website
galectintherapeutics.comPhone
(678) 620-3186Employees
11
About Galectin Therapeutics
Galectin Therapeutics is a US-based company with approximately 11 employees. The company is focused on developing proprietary galectin inhibitors and discovering new treatments for diseases such as non-alcoholic steatohepatitis (NASH) cirrhosis, fibrosis, and cancer. Their lead drug candidate, belapectin, is currently in clinical trials for NASH cirrhosis.